Which description best distinguishes explanatory (efficacy) trials from management (effectiveness) trials?

• A. Explanatory trials assess treatment efficacy using pre-protocol analysis; management trials assess effectiveness using intention-to-treat analysis.
• B. Explanatory trials assess safety; management trials assess cost-effectiveness.
• C. Explanatory trials measure real-world outcomes; management trials measure biological mechanisms.
• D. Explanatory trials use blinding; management trials do not use any blinding.

Answer: (A)

The main idea is the difference between testing whether an intervention can work under ideal conditions versus whether it does work in real-world practice. Explanatory (efficacy) trials are designed to determine if the treatment works when everything is tightly controlled and participants are highly adherent. To reflect that, they often analyze data from those who followed the protocol as intended (pre-protocol or per-protocol analyses), which can show the treatment’s effect in a best-case scenario but may bias results if adherence is not perfect.

Management (effectiveness) trials aim to see how well the intervention performs in typical clinical settings with diverse patients and various adherence levels. To mirror real-world use, they usually analyze data by intention-to-treat, which includes all randomized participants regardless of adherence, preserving the randomization and giving a more generalizable estimate of effectiveness.

So the choice describing explanatory trials using pre-protocol analysis and management trials using intention-to-treat analysis best captures this distinction. The other options mix aspects like safety vs cost-effectiveness, real-world outcomes vs mechanisms, or blinding, none of which corely define the explanatory versus effectiveness contrast.